Pregnancy & Ovulation Testing Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The Asia Pacific pregnancy and ovulation testing market is anticipated to touch USD 298.68 billion by 2023, as per an insightful report by Market Research Future (MRFR). It is expected to exhibit a 6.1% CAGR during the assessment period (2018-2023). The increasing acceptance of home testing kits to check the possibility of pregnancy is projected to spur market demand during the forecast period.

Pregnancy tests are kits capable of detecting hormones such as human chorionic gonadotropin (hCG) in urine. Ovulation tests, on the other hand, are capable of detecting an uptick in luteinizing hormone (LH) to decide the optimal time for conceiving children. Availability of ovulation monitors on e-commerce websites, awareness of fertility tests, and awareness of these tests made possible by various promotional marketing activities by major brands are likely to lead to an uptick in market demand over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6198 

Digitization of results to provide privacy to consumers has been made possible owing to pervasiveness of smartphones. For instance, the FIRST RESPONSE Pregnancy PRO Digital Test & App Access by Church & Dwight Co., sends accurate results to the consumer’s smartphone. But high costs of ovulation tests can act as a market deterrent.

Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the Asia Pacific (APAC) market for pregnancy and ovulation testing. By correlating the historical data with key market dynamics, our analysts can make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the APAC market segmented by type, mode of purchase, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview

By type, the Asia Pacific pregnancy and ovulation testing market has been segmented into pregnancy and ovulation testing. The pregnancy testing segment is sub-segmented into blood-based and urine-based testing. This segment is touted to garner above average demand owing to advances in pregnancy testing kits and alarming cases of polycystic ovary syndrome (PCOS). Similarly, the ovulation testing segment is sub-segmented into fertility monitors and ovulation prediction kits.

By mode of purchase, the market is segmented into prescription and non-prescription testing/over-the-counter (OTC) testing.  The non-prescription testing mode of purchase is projected to experience remarkable growth thanks to preference for home pregnancy tests and privacy concerns among women.

By end-user, the market is segmented into fertility centers, hospitals and clinics, and others. The hospitals and clinics segment is likely to register a 5.8% CAGR during the forecast period owing to their propensity to handle large patient volumes.

The segments and sub-segments covered in the report are analyzed under six major regions – India, China, Japan, Republic of Korea, Australia, and Rest of Asia Pacific, with respective country-level market sizing. For the scope of research, the standard definition of the product/service “pregnancy and ovulation testing” is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.

Players Covered

Gregory Pharmaceutical Holdings, Inc., Proctor & Gamble, TaiDoc Technology & Corporation, Mankind Pharma Ltd., Geratherm Medical AG, Fairhaven Health, LLC, Quidel Corporation, Piramal Enterprises Ltd., Cadila Healthcare Limited, and Church & Dwight Co., Inc., are noteworthy players in the Asia Pacific pregnancy and ovulation testing market.

The report offers comprehensive profiles on these market players and assesses their current standing in the Asia Pacific pregnancy and ovulation testing market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are outlined in the report.

Browse more deatails of Report @ https://www.marketresearchfuture.com/reports/asia-pacific-pregnancy-ovulation-testing-market-6198 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Magnetic Resonance Imaging (MRI) Systems Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The global Magnetic Resonance Imaging (MRI) Systems market is expected to be of value USD 5 Billion in 2023 and to grow at a depict 3.5% CAGR during the forecast period.  Magnetic resonance imaging (MRI) systems is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. Magnetic resonance imaging (MRI) systems are surpassing the radiology imaging market due to its myriad advantages over it. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of magnetic resonance imaging (MRI) systems techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market. However, the market growth is restricted by factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for magnetic resonance imaging (MRI) systems procedures.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6194  

Market Segmentation                                                                                                                          

The global magnetic resonance imaging (MRI) systems market is segmented on the basis of type, field strength, disease application and end user.

Considering the type, the market is segmented into open MRI, closed MRI, standard bore MRI, wide-bore MRI.

On the basis of field strength, the market is segmented into high-field MRI systems, 1.5t MRI systems, 3t MRI systems, low-to-mid-field MRI systems, very-high-field MRI systems, and others.

On account of disease application, the market is segmented into the spine and musculoskeletal MRI, brain and neurological MRI, pelvic and abdominal MRI, breast MRI, cardiovascular MRI, and others

According to the end user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Market Players

• Hitachi
• Siemens AG
• Canon Medical Systems
• GE Healthcare
• Philips
• Toshiba Corporation
• Toshiba Corporation
• Xingaoyi
• Aurora Imaging Technologies, Inc.

Regional Market Summary

In terms of geography, Americas dominates the market for Magnetic Resonance Imaging (MRI) systems owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders pertaining to rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in the medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems, and the presence of pharmaceutical giants also propel the market growth in this region. For instance, according to National Center for Health Statistics report in 2016, around 140,323 mortality occurred due to cerebrovascular disease or stroke in the US Thus, this rising patient pool is going to boost up the market growth during the forecast period.

Europe accounts for the second largest market and holds a healthy share in the global magnetic resonance Imaging (MRI) systems market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of Magnetic Resonance Imaging (MRI) Systems over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.

Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the Department of Neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period.  Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in  Magnetic Resonance Imaging (MRI) Systems market in future.

 The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. Hence, the market might show steady growth due to Saudi Arabia, the UAE market growth, and government initiatives to improve quality of healthcare in the Africa region.

Browse more deatails of Report @ https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-market-6194 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Needle Free Injection Market: Segmentation, Industry trends and Development to 2027

 The global needle free injection market is anticipated to reach USD 25,057.4 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2018-2023). Prevalence of various chronic diseases is propelling the need for needle free injections. Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care is projected to drive market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6180 

Needle free injections are syringes which deliver drugs through direct contact with the skin instead of a hypodermic needle. They can be used by children, adults, and patients with allergic conditions without any doctor supervision. It can prevent needle stick injuries, which is a common factor of disease transmission. Increasing incidence of diabetes is anticipated to induce market demand in the coming years. But high cost of these devices and cross-contamination risks can deter market growth.

Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for needle free injections. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global needle free injection market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview

By product type, the needle free injection market has been segmented into prefilled and fillable needle free injectors. By technology, the market is segmented into laser-powered, spring-based, and jet-based. By usability, the market is segmented into disposable and reusable needle free injectors.  

By medication type, the market is segmented into projectile/depot-based, powder-based, and liquid-based needle free injectors. By site of delivery, intradermal, intramuscular, and subcutaneous are segments in the market. Oncology, vaccination, insulin delivery, and others are major market applications. Prime end-users include ambulatory surgical centers, homecare settings, hospitals and clinics, and others.

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “needle free injection” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.

Players Covered

CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D'Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group are prominent players in the needle free injection market.

The report offers comprehensive profiles on these market players and assesses their current standing in the needle free injection market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.

Browse more deatails of Report @ https://www.marketresearchfuture.com/reports/needle-free-injection-market-6180 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Saudi Arabia Medical Devices Market Top Companies, Business Insights, Growth, Global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis 2027

 A medical device is any instrument, appliance including any software, biologic or non-biologic material, to be used for the diagnostic or therapeutic use for management of diseases and disorders.

The medical device industry witnessed one of the fastest growth propelled by innovation and rapid uptake of technologies. The medical devices industry has also resulted in the successful fusion of information technology and healthcare. Technology and product development remain the main pillars for the growing market for medical devices. The market involves two segments one high-tech devices with extreme sophistication and another is the low tech improved devices. The high tech segment such as diagnostic imaging devices is witnessing higher rates of growth. The low tech segment is also growing at a good rate but has witnessed growth in developing regions as the market for these in developed regions is stagnant. The other market driving factors are rising public healthcare expenditure in Saudi Arabia, development of large hospitals such as King Faisal hospital in Riyadh, demand for noninvasive therapy etc.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2801 

The market constraints are strict and ambiguous regulatory framework, growing concern for security especially data security, differential availability between developed and developing regions, connectivity issues in Saudi Arabia, the interference Sharia courts etc.

The future developments will include cloud integration, connected healthcare devices and growing demand for personalized medical wearable devices. Healthcare mobile applications will also lead the market.

Saudi Arabia Medical Devices Market:

The Saudi Arabia Medical Devices market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The Saudi Arabia medical devices market is expected to grow with CAGR of ~9.5 % during the forecast period. The growth will be primary channeled by the rising public healthcare expenditure. The falling crude oil revenues will be a future threat to the market.

The major participants of this market are: Johnson & Johnson, General Electric, Medtronic, Koninklijke Philips Electronics NV., Baxter Internationa, Fresenius Medical Care AG & Co., Cardinal Health, Al-Salehiya Medical Estableshment, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Al Amin Medical Instruments Company (AMICO), Al Faisaliah Medical Systems (FMS), Siemens Ltd and others.

Regional Analysis:

The healthcare sector of Saudi Arabia is divided between private and state. The public healthcare expenditure accounts for approximately 75% of total health expenditure in 2014. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles. The government has established some of the best hospitals in the region such as King Faisal specialist hospital and research center, Riyadh military hospital, Saudi Arabia’s National Guard health affairs hospital etc. Saudi Arabia is extremely dependent on imports for medical devices and imports account for approximately 92% of total market for medical devices. U.S. medical device suppliers dominate the scenario with European vendors in the second position. Among the regions of Saudi Arabia Riyadh tops the healthcare expenditure list followed by Tabuk, Makkah and Madina. 

Segmentation:

Saudi Arabia medical devices market has been segmented on the basis of product type which comprises monitoring devices, diagnostic devices, diagnostic molecular devices, drug delivery devices, surgical devices, bio implants and stimulation devices, automation and robotics and others. On the basis of therapeutic application; market is segmented into general surgery, diagnostic imaging, respiratory, orthopedics, cardiovascular, dental, neurology, ophthalmology, ear-nose-throat (ENT), nephrology and urology, and others. On the basis of end users; market is segmented hospitals, ambulatory, home and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/saudi-arabia-medical-devices-market-2801 

Orthopedic Trauma Devices Market Insights Analysis 2020-2027

 The global market for orthopedic trauma devices is projected to register CAGR of 8% during the forecast period (2015-2022), as predicted by Market Research Future (MRFR). Increasing number of trauma associated with road accidents and other causes is expected to fuel the market growth. Rising geriatric population also aides the growth of the orthopedic trauma devices market, as people in this age group are highly prone to bone fractures resulting from fall injury and other orthopedic complications. It has also been observed that an increasing number of people are getting interested in some form of sport, owing to increasing awareness about one’s health. This has resulted in an accelerated number of injuries associated with sport, thus having a knock-on effect on the global market size. Moreover, a handful of companies are involved in the development and marketing of orthopedic trauma devices, thereby leading to the market to evolve with growth opportunity.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2080 

But the market is not without its challenges as poor healthcare infrastructure in few developing economies impedes the said market growth. However, looking at the bright side, the industry is discovering new applications in orthopedics on the back of advances in 3D printing. Subsequently, 3D printed implants are trending rapidly across the globe. Also, the market is apprehended to attain massive revenues in coming years due to another market trend, namely reverse shoulder arthroplasty.

Market Segmentation

The global orthopedic trauma device market is segmented on the basis of material type, product type and end-users.

The material types in the market are bio-absorbable materials, non-absorbable materials and others. The applications of bio-absorbable implants in orthopedic surgery are primarily mandated from the need to eliminate implant removal operations, thus gaining widespread popularity among orthopedic surgeons. Consistent development and product enhancement have given significant push to the bio-absorbable materials segment in the global market.

The product types in the global market are screws, plates, patient specific implants and others. The market for screws is expected to retain a massive share of the market due to favorable reimbursement policies and its wide array of applications in orthopedic surgeries. Moreover, benefits of orthopedic screws make them highly favorable, such as non-interference with MRI, decreased incidence of graft laceration and do not need implant removal. The end-users in the global market include hospitals, rehabilitation centers, clinics and others.

Regional Analysis

Globally, North America currently occupies the largest market for global orthopedic trauma devices market and is bound to secure its top position in the global market throughout the forecast period. Soaring use of bio-absorbable plates and screws is mainly fuelling the orthopedic trauma devices market in the region. Also, the region is witnessing robust sales of hybrid plates and screws, which will work in favor of the market growth in coming years. On top of that, intramedullary nails are steadily gaining traction in the majority of orthopedic surgeries owing to their increasing popularity as an ideal orthopedic trauma device for various anatomies, in the region.

Closely following the North America region stands the region of Europe, securing the second position in the global orthopedic trauma devices market. Trending incorporation of robotics technology during orthopedic surgeries is presumed to push the market in the region. The market also thrives on the back of constantly flourishing medical industry with well-established healthcare infrastructure.

According to the report, the Asia Pacific region is projected to be the fastest growing market. On the backdrop of an expanding market in developing nations in the region, flourishing medical tourism will continue to trigger the market for orthopedic trauma devices. Moreover, growing preference for minimally invasive fixation is expected to provide a tremendous thrust to the regional market as well. Growing geriatric population and increasing number of cases of injuries and road accidents also help the market captivate the region to a large extent.

The Middle East and Africa markets are exhibiting a positive outlook in terms of market expansion. This can be attributed to manufacturers consistently investing in research and development (R&D) activities to develop innovative and efficient devices, to cater to the growing demand. Large number of R&D activities is presumed to ensure enhanced growth opportunities during the forecast period. Moreover, increasing awareness regarding availability of innovative products among patients is pushing the market to higher levels in the region.

Key Players

Some of the key players in this market are: Invibio (UK), BIOTEK (India), DePuy Synthes Companies, Ortho Max Manufacturing Company Pvt. Ltd., Auxein Medical (India), Stryker, Johnson & Johnson Services, Inc. (US), Smith & Nephew, MEDTRONIC, B. Braun Melsungen AG and others.

Industry Developments

In June 2018, CoreLink acquired Expanding Orthopedics, a privately held medical device developer. The acquisition provides CoreLink with many benefits including growth in the inter-body product category along with growth in the portfolio of innovative orthopedic technology for advanced spine care. The acquisition will also boost the appeal of CoreLink’s recently launched FLXfit and FLXfit 15 titanium interbody systems.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orthopedic-trauma-devices-market-2080 

Global MHealth Market size and forecast, 2020-2027

 The global mHealth market is one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory workflow and the intense competitive rivalry among large number of public companies. Mobile health (mHealth) is also one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the increasing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. The various factors that influence the growth of mHealth market are patient’s involvement in personal healthcare, implementation of smartphones and wearable devices into healthcare industry, integration of wireless technologies with healthcare devices that are portable, benefits of Cost effectiveness and patients’ convenience and Increase in lifestyle diseases. Globally the market for mHealth is expected to grow at 36.5% CAGR (2016-2022).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1816 

Key Players for mHealth Market
Some of the key players in this market are: Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others.

Key Finding

• The mHealth global market is expected to reach $ 21.71Billion by 2022.
• Americas holds the largest market share of 34% of mHealth market globally.
• Europe market is expected to grow at a CAGR of 35.65%.
• Monitoring application segment hold 61.8% market share of global mHealth market by application.

 mHealth Market Segments      

 

mHealth market has been segmented on the basis of therapeutics which comprises of diabetes, respiratory, mental and neurological disorders, fitness & lifestyle therapeutics and others. Whereas on the basis of application the market is segmented into monitoring applications, diagnosis & treatment, education and awareness, healthcare management, wellness & prevention, remote data collection

Regional Analysis of mHealth Market                                                                      

 

Globally Americas is the largest market for mHealth market. The large size of the market can be attributed due to increasing digital advancement in medical technology. Asia-Pacific is the second-largest for mHealth market. Europe mHealth market is expected to grow with a steady pace.                         

North America

• US
• Canada

Europe

• Germany
• France
• Italy
• Spain
• UK
• Rest of Europe

Asia

• China
• India
• Japan
• South Korea
• Rest of Asia
• Pacific

Latin America, Middle East & Africa

The report for mHealth market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mobile-health-market-1816 

Oral Mucositis Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The global Oral Mucositis Market size is expected to register 7.1% CAGR during the forecast period of 2019 to 2025, with a market value of USD 2,247 million in 2018. Oral mucositis is an acute inflammation or ulceration of the oral or oropharyngeal mucosal membranes. It can cause pain/discomfort, interfere with swallowing, eating, and speech, and may lead to infection. The global oral mucositis market is driven by factors such as rising incidences of cancer globally and increasing oral mucositis drug development. For instance, according to the National Center for Biotechnology Information, oral mucositis occurs in up to 40% of cancer patients that receive chemotherapy and approaches 100% in the treatment of head and neck cancers. Additionally, according to National Cancer Institute, an estimated 1,735,350 new cases of cancer were diagnosed in the US in 2018. Furthermore, according to the US Department of Health and Human Services, the prevalence of cancer in the US is 439.2 per 100,000 men and women. Moreover, according to WHO, there are 3.7 million cases of cancer in Europe every year. On the other hand, most of the drugs are not to be ingested, which restricts their usage for oral mucositis is projected to hamper the growth of the market during the assessment period. Moreover, major companies in the market are involved in strategic acquisitions, collaborations, and mergers, and receive new patents to sustain their position in the market. For instance, in February 2019, Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis. The patent covers methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1531 

Oral Mucositis Market Segmentation

The global oral mucositis market has been segmented based on cause, end user, and region.

The market, based on cause, has been bifurcated into oral mucositis caused by chemotherapy, oral mucositis caused by radiotherapy, and oral mucositis caused by hematopoietic stem cell transplantation

The global market, based on end user, has been segmented into hospitals, dental clinics, oncology hospitals, and research institutes. Based on cause, the oral mucositis caused by chemotherapy segment is expected to hold a major share in the market as chemotherapy is widely used as a treatment method for cancer. For example, according to the US Department of Health & Human Services, every year, about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic in the US. Based on end user, the hospitals segment is expected to hold a major share in the market due to its close association with cancer availability of all possible treatment options.

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The oral mucositis market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European oral mucositis market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The oral mucositis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The oral mucositis market in the Middle East & Africa has been divided into the Middle East and Africa.

Global Oral Mucositis Market, by Cause

• Oral Mucositis Caused by Chemotherapy
• Oral Mucositis Caused by Radiotherapy
• Oral Mucositis Caused by Hematopoietic Stem Cell Transplantation

Global Oral Mucositis Market, by End User

• Hospitals
• Dental Clinics
• Oncology Hospitals
• Research Institutes

Key Players

The key players operating in the global oral mucositis market are Izun Pharmaceuticals Corporation, Shoreline Pharmaceuticals, Inc, AMAG Pharmaceutical Inc, Innovation Pharmaceuticals, The Himalaya Drug Company, Access pharmaceuticals, EKR therapeutics Inc, EUSA Pharma Inc, Swedish Orphan Biovitrum AB (publ), Soligenix, and Daewoong Co. Ltd.

Regional Market Summary:

Source: World Health Organization (WHO) The market in the Americas is expected to dominate the oral mucositis market due to the increasing incidences of head and neck cancers. For example, according to the American Society of Clinical Oncology (ASCO), head and neck cancer account for about 4% of all cancers in the US. In 2019, an estimated 65,410 people will develop head and neck cancer. High cases of cancer in the US and Canada is expected to drive the market growth. Furthermore, increasing expenses in research by healthcare bodies engaged in improving oral mucositis treatment are the factors contributing to its largest share is expected to fuel the growth of the market in this region. The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, an increase in cancer diseases, and the involvement of key companies. For instance, in April 2016, EUSA Pharma announces the acquisition of global rights to next-generation oncology supportive care product Arcoral Tab from Arcoral Pharma. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing prevalence of cancer and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low per capita disposable income in the region. 

Browse more details of Report @ https://www.marketresearchfuture.com/reports/oral-mucositis-market-1531 

   
About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com